U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2016
495
Name Type Language
ATEZOLIZUMAB
DASH   INN   USAN   WHO-DD  
INN   USAN  
Official Name English
ATEZOLIZUMAB [USAN]
Common Name English
TECENTRIQ
Common Name English
RG-7446
Code English
ATEZOLIZUMAB [JAN]
Common Name English
MPDL3280A
Code English
ATEZOLIZUMAB [MI]
Common Name English
atezolizumab [INN]
Common Name English
AN ANTIBODY TO PROGRAMMED DEATH LIGAND 1 FOR CANCER THERAPY
Common Name English
ATEZOLIZUMAB [PURPLE BOOK CDER]
Common Name English
0INE2SFD9E
Common Name English
RG7446
Code English
Atezolizumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MPDL3280A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MPDL3280A .KAPPA.-CHAIN, DIMER
Common Name English
MPDL-3280A
Code English
Classification Tree Code System Code
WHO-ATC L01XC32
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 574817
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 619317
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 792320
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 769320
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 541216
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 550616
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
NDF-RT N0000191260
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
NCI_THESAURUS C128057
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL3707227
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
LACTMED
Atezolizumab
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
DRUG BANK
DB11595
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
WIKIPEDIA
Atezolizumab
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
SMS_ID
100000163921
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
NCI_THESAURUS
C106250
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
EVMPD
SUB178312
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
NDF-RT
N0000011175
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY Antibodies [Chemical/Ingredient]
NDF-RT
N0000183512
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY Antibodies, Monoclonal, Humanized [Chemical/Ingredient]
DAILYMED
52CMI0WC3Y
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
INN
9814
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
FDA UNII
52CMI0WC3Y
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
CAS
1380723-44-3
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
USAN
CD-146
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
RXCUI
1792776
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
DRUG CENTRAL
5151
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
CAS
1422185-06-5
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
NO STRUCTURE GIVEN
MERCK INDEX
m11954
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
NDF-RT
N0000191259
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY Programmed Death Receptor-1-directed Antibody Interactions [MoA]
ACTIVE MOIETY
ATEZOLIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966